New cream shows promise for soothing hemorrhoid pain

NCT ID NCT06944951

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a medical device cream called PROCTOeze® PLUS in 50 adults with mild to moderate hemorrhoids (Grade I-II). Participants applied the cream at home for 14 days to see if it improved symptoms and quality of life. The study measured changes using a short health questionnaire and a doctor-rated severity score.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PROCTOeze® PLUS (hydrophilic emulsion cream)
What this could lead to
If it works, this cream could offer a safe, non-drug option for easing hemorrhoid symptoms and improving quality of life.
What could go wrong
This is a small, completed post-market study with only 50 participants and no comparison group, so results may not apply to everyone. The cream only treats symptoms, not the underlying condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMORRHOIDAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • C.M.I. Sisu Lucia Cristina

    Craiova, Dolj, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.